| Autor: |
Chong JT; United Urology Group, Chesapeake Urology, Hanover, Maryland, USA.; United Urology Group, Colorado Urology, Lafayette, Colorado, USA., Dunne M; United Urology Group, Chesapeake Urology, Hanover, Maryland, USA.; Department of Urology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Magnan B; Department of Urology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Abbott J; Pacific West Urology, Las Vegas, Nevada, USA., Davalos JG; United Urology Group, Chesapeake Urology, Hanover, Maryland, USA.; Department of Urology, University of Maryland School of Medicine, Baltimore, Maryland, USA. |
| Abstrakt: |
Introduction: Percutaneous nephrolithotomy (PCNL) is an effective procedure for removal of large kidney stones; however, PCNL has traditionally been reserved for inpatient surgery. Certain cases are being performed entirely at an ambulatory surgery center (ASC), known as ambulatory PCNL (aPCNL). Materials and Methods: Five hundred consecutive PCNL procedures performed at a free-standing ASC between April 2015 and February 2019 were analyzed. Patient demographics, stone characteristics, operative characteristics, and postoperative data, including transfer to hospitals, 30-day readmissions, and complications > Clavien I, were recorded. Results: The mean age of patients undergoing PCNL at the ASC was 57 (range: 16-86) and body mass index 30 (16-49). American Society of Anesthesiologists (ASA) compositions are as follows: ASA 1 (6.5%), ASA 2 (56.2%), ASA 3 (37.2%), and ASA 4 (0. 1%). The mean stone burden was 30 mm (5-140). Standard tract dilation (24-30F) comprised 77% of cases. Ninety-two percent of cases were performed with a single tract, and 99% of cases had a ureteral stent as the only form of drainage (tubeless PCNL). The mean operative time was 104 minutes (32-305), and postanesthesia care unit time was 97 minutes (37-247). The predicted stone-free rate was 84%. Twelve patients (2.4%) required transfer to hospital, and the 30-day readmission rate was 4.2%. Conclusion: aPCNL is a safe and feasible procedure if performed by a high volume endourologist, even within the confines of a free-standing ASC. It is our opinion that the utilization of endoscopic combined intrarenal surgery facilitates high stone-free rates with minimal morbidity and low readmission rates. The institutional review board number is WIRB # 20171472. |
